(Q70916733)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozotocin-induced diabetes in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

author name string

V Esposito

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

M V Latronico

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

F A Pisanti

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

publication date

1 February 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Pancreatology

14 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

63-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM

14 October 2019

cites work

1 reference

12 December 2020

Prevention of low dose streptozotocin-induced diabetes by acetyl-homocysteine-thiolactone

1 reference

12 December 2020

Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation

1 reference

12 December 2020

What are the types and cellular sources of free radicals in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus?

1 reference

12 December 2020

Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide

1 reference

12 December 2020

Interleukin-1 beta induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages

1 reference

12 December 2020

Nitric oxide: a pathogenetic factor in autoimmunity

1 reference

12 December 2020

Cytotoxicity of activated rat macrophages against syngeneic islet cells is arginine-dependent, correlates with citrulline and nitrite concentrations and is identical to lysis by the nitric oxide donor nitroprusside

1 reference

12 December 2020

The 12th International Immunology and Diabetes Workshop. Orlando, Florida.

1 reference

12 December 2020

Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozocin-induced insulitis

1 reference

12 December 2020

Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice

1 reference

12 December 2020

Involvement of O2 radicals in 'autoimmune' diabetes

1 reference

12 December 2020

Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells

1 reference

12 December 2020

Acetyl-homocysteine-thiolactone-induced increase of superoxide dismutase counteracts the effect of subdiabetogenic doses of streptozocin.

1 reference

12 December 2020

Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism

1 reference

12 December 2020

Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02788360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8568336%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference